Viridian Therapeutics Ownership | Who Owns Viridian Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Viridian Therapeutics Ownership Summary

Viridian Therapeutics is owned by 128.24% institutional investors, 0.40% insiders. Fmr is the largest institutional shareholder, holding 17.89% of VRDN shares. Fidelity Select Health Care is the top mutual fund, with 2.82% of its assets in Viridian Therapeutics shares.

VRDN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Viridian Therapeutics	128.24%	0.40%	-28.65%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	11.88M	17.89%	$227.78M
Blackrock funding, inc. /de	5.76M	8.67%	$110.39M
Blackrock	4.77M	7.81%	$62.10M
Vanguard group	4.60M	6.92%	$88.09M
Deep track capital, lp	4.52M	6.81%	$86.70M
Vr adviser	3.88M	5.85%	$74.43M
Fairmount funds management	3.45M	5.19%	$66.06M
Kynam capital management, lp	3.33M	5.01%	$63.76M
State street	2.77M	4.54%	$36.07M
Tang capital management	2.49M	3.75%	$47.79M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Great point partners	750.00K	6.78%	$14.38M
Fairmount funds management	3.45M	6.57%	$66.06M
Vr adviser	3.88M	5.11%	$74.43M
Cutter capital management, lp	628.68K	4.94%	$12.05M
Kynam capital management, lp	3.33M	3.77%	$63.76M
Commodore capital lp	2.40M	3.37%	$46.01M
5am venture management	736.60K	3.37%	$14.12M
Deep track capital, lp	4.52M	3.23%	$86.70M
Tang capital management	2.49M	3.16%	$47.79M
Parkman healthcare partners	1.09M	2.78%	$20.85M

Top Buyers

Holder	Shares	% Assets	Change
Loomis sayles & co l p	1.40M	0.03%	1.40M
Price t rowe associates inc /md/	1.33M	0.00%	1.28M
Blackrock	4.77M	0.00%	960.99K
Blackrock funding, inc. /de	5.76M	0.00%	954.57K
Kynam capital management, lp	3.33M	3.77%	814.97K

Top Sellers

Holder	Shares	% Assets	Change
Ecor1 capital	-	-	-1.96M
State street	2.77M	0.00%	-1.72M
Perceptive advisors	1.49M	0.79%	-1.33M
Paradigm biocapital advisors lp	1.82M	1.21%	-1.08M
Polar capital	-	-	-889.20K

New Positions

Holder	Shares	% Assets	Change	Value
Loomis sayles & co l p	1.40M	0.03%	1.40M	$26.84M
Victory capital management	410.44K	0.01%	410.44K	$7.87M
Raymond james financial	313.79K	0.00%	313.79K	$6.02M
Bnp paribas arbitrage, snc	203.85K	0.00%	203.85K	$3.91M
Silverarc capital management	100.00K	0.42%	100.00K	$1.92M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-8.00
Parallel advisors	-10.00
Game plan financial advisors	-13.00
Harbour investments	-66.00
National bank of canada /fi/	-100.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	186	6.29%	85,180,374	-2.05%	128	0.75%	118	7.27%	40	-4.76%
Sep 30, 2024	173	18.49%	86,676,793	24.72%	130	1.01%	111	24.72%	40	37.93%
Jun 30, 2024	146	2.10%	69,497,343	-1.95%	113	0.85%	89	2.30%	29	-12.12%
Mar 31, 2024	143	2.88%	70,881,269	17.87%	116	0.79%	87	19.18%	33	-25.00%
Dec 31, 2023	139	10.32%	60,136,748	19.81%	121	0.92%	73	5.80%	44	25.71%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Select Health Care	2.30M	2.82%	20.30K
Vanguard US Total Market Shares ETF	2.24M	2.75%	324.50K
Vanguard Total Stock Mkt Idx Inv	2.22M	2.72%	-
iShares Russell 2000 ETF	1.95M	2.40%	-16.94K
Fidelity Advisor Biotechnology I	1.56M	1.92%	-
Fidelity Advisor Health Care I	1.38M	1.69%	12.00K
SPDR® S&P Biotech ETF	1.30M	1.59%	-13.90K
Fidelity Small Cap Growth	1.05M	1.29%	-
Vanguard Institutional Extnd Mkt Idx Tr	1.05M	1.29%	1.59K
FIAM Small Cap Core CIT Cl B	1.01M	1.24%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 27, 2024	Beetham Thomas W.	Chief Operating Officer	Buy	$117.05K
Sep 27, 2024	Mahoney Stephen F.	President and CEO	Buy	$499.26K
Sep 13, 2024	Fairmount Funds Management LLC		Buy	$30.00M
Jan 22, 2024	Fairmount Funds Management LLC	See Remarks	Buy	$10.00M
Jun 16, 2023	Meisner Lara	Chief Legal Officer	Sell	$765.45

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q3	3	-
2024 Q2	-	-
2024 Q1	1	-

VRDN Ownership FAQ

Who Owns Viridian Therapeutics?

Viridian Therapeutics shareholders are primarily institutional investors at 128.24%, followed by 0.40% insiders and -28.64% retail investors. The average institutional ownership in Viridian Therapeutics's industry, Biotech Stocks , is 68.48%, which Viridian Therapeutics exceeds.

Who owns the most shares of Viridian Therapeutics?

Viridian Therapeutics’s largest shareholders are Fmr (11.88M shares, 17.89%), Blackrock funding, inc. /de (5.76M shares, 8.67%), and Blackrock (4.77M shares, 7.81%). Together, they hold 34.37% of Viridian Therapeutics’s total shares outstanding.

Does Blackrock own Viridian Therapeutics?

Yes, BlackRock owns 7.81% of Viridian Therapeutics, totaling 4.77M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 62.1M$. In the last quarter, BlackRock increased its holdings by 960.99K shares, a 25.21% change.

Who is Viridian Therapeutics’s biggest shareholder by percentage of total assets invested?

Great point partners is Viridian Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.78% of its assets in 750K Viridian Therapeutics shares, valued at 14.38M$.

Who is the top mutual fund holder of Viridian Therapeutics shares?

Fidelity Select Health Care is the top mutual fund holder of Viridian Therapeutics shares, with 2.82% of its total shares outstanding invested in 2.3M Viridian Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools